Merdrignac, L., Lanièce Delaunay, C., Verdasca, N., Vega-Piris, L., O'Donnell, J., Sève, N., Trobajo-Sanmartín, C., Buda, S., Hooiveld, M., Rodrigues, A.P., Túri, G., Latorre-Margalef, N., Mlinarić, I., Lazar, M., Maurel, M., Castrillejo, D., Bennett, C., Rameix-Welti, M.A., Martínez-Baz, I., Dürrwald, R., Meijer, A., Melo, A., Oroszi, B., Samuelsson Hagey, T., Kurečić Filipović, S., Dijkstra, F., Gómez, V., Bacci, S., Kaczmarek, M., Kissling, E.
Effectiveness of XBB.1.5 vaccines against symptomatic SARS-CoV-2 infection in older adults during the JN.1 lineage-predominant period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024